---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-097138"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2025-10-06T23:59:59+00:00"
generated_at: "2026-05-17T04:35:13.606140+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics acquires GridAI in share exchange; former GridAI holders to own 82.5% of diluted ENTO

## Summary
- Acquired 100% of GridAI for 424,348 common shares (19.99% of outstanding) and 38,801,546 Series H convertible shares.
- Upon conversion (subject to shareholder approval), former GridAI stockholders will own 82.5% of ENTO on a fully diluted basis.
- GridAI is a grid-edge AI platform managing behind-the-meter assets; over $50M invested since 2019.
- ENTO must raise at least $3M in gross proceeds within 30 days post-closing and maintain $2M cash minimum.
- Former GridAI shareholders get right to designate 2 directors initially, eventually 5 of 7 board seats.

## SEC filing metadata
- accession: 0001104659-25-097138
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2025-10-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 5.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465925097138/0001104659-25-097138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465925097138/tm2528018d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-097138
- JSON: https://secwatch.observer/filing/0001104659-25-097138.json
- Plain text: https://secwatch.observer/filing/0001104659-25-097138.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.